Safety and Efficacy of Trans-arterial Versus Trans-portal ICG Fluorescence-Guided Laparoscopic Liver Watershed Resection: A Multicenter, Ambispective Cohort Study
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Procedure
Study Type: Observational
SUMMARY
This multicenter, ambispective cohort study evaluates the safety and efficacy of trans-arterial Indocyanine Green (ICG) fluorescence-guided laparoscopic liver watershed resection for Hepatocellular Carcinoma (HCC). The study aims to compare the outcomes of the trans-arterial ICG staining approach versus the conventional trans-portal (portal vein) ICG staining approach.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• Age 18-80 years.
• Postoperative histopathological diagnosis of Hepatocellular Carcinoma (HCC).
• Underwent ICG fluorescence-guided laparoscopic anatomical liver resection.
• Child-Pugh Class A or B.
• ASA score I-III.
• ECOG Performance Status 0-2.
• No invasion of major vessels (main portal vein/first-order branches, main hepatic vein).
• No distant metastasis.
Locations
Other Locations
China
Beijing Tsinghua Changgung Hospital
RECRUITING
Beijing
West China Hospital
RECRUITING
Chengdu
Xuzhou Central Hospital
RECRUITING
Xuzhou
Contact Information
Primary
Jiwei Huang Professor
huangjiwei@wchscu.cn
18980606725
Time Frame
Start Date: 2026-03-01
Estimated Completion Date: 2028-09-01
Participants
Target number of participants: 200
Treatments
Transarterial ICG Group
Patients who underwent laparoscopic anatomical liver resection guided by superselective transarterial injection of ICG.
Transportal ICG Group
Patients who underwent laparoscopic anatomical liver resection guided by transportal (portal vein) injection of ICG.
Related Therapeutic Areas
Sponsors
Leads: West China Hospital